Abstract
Blastoschizomyces capitatus represents an emerging fungal pathogen in acute leukemia patients. The susceptibility to amphotericin B, 5-fluorocytosine, ketoconazole and fluconazole of nine clinical isolates was evaluated. A specific medium (high resolution medium) was used for testing fluconazole. This agent and 5-fluorocytosine were at least four- to eight-fold more active than amphotericin B and ketoconazole against all isolates but one.
| Lingua originale | Inglese |
|---|---|
| pagine (da-a) | 13-15 |
| Numero di pagine | 3 |
| Rivista | Journal of Chemotherapy |
| Volume | 3 |
| DOI | |
| Stato di pubblicazione | Pubblicato - 1991 |
Keywords
- Antifungal Agents
- Fluconazole
- Geotrichum
- Microbial Sensitivity Tests
- Mitosporic Fungi
- Trichosporon